The ability of the testis to convert irreversibly androgens into estrogens is related to the presence of a microsomal enzymatic complex named aromatase. In rodents, germ cell production of estrogens is known, although the regulation of the cytochrome P450 aromatase (P450 arom) gene expression is not completely elucidated. In the present study, we have investigated the putative effects of steroids (testosterone, 5α-dihydrotestosterone (DHT) and estradiol) on Cyp19 gene expression in purified adult rat pachytene spermatocytes (PSs) and round spermatids (RSs). Using a highly specific quantitative competitive RT-PCR method we established that testosterone enhances in a dose-and time-related manner aromatase gene expression in PSs and RSs; 5α-DHT induces the same effect. Furthermore, testosterone increases the estradiol output in both germ cell populations whereas 5α-DHT was inefficient, therefore suggesting that the effect of androgens on P450 arom gene transcription was independent of estrogen formation. In fact estradiol inhibits the Cyp19 gene expression in PSs and RSs. ICI 182780, an estrogen receptor antagonist, has no effect on testosterone-stimulated aromatase expression in PSs and RSs. By contrast, ICI 182,780 suppresses the inhibitory effect of estradiol on P450 arom mRNA expression in PSs and RSs. Similarly, nilutamide, a non-steroidal anti-androgen specific for androgen receptors, abolishes the testosterone-stimulated aromatase expression in PSs and RSs. These observations show that androgens up-regulate aromatase gene expression in purified adult rat germ cells whereas estrogens exert an opposite effect, which may suggest the presence of androgen and estrogen responsive elements on the aromatase promoter(s).
Introduction
In males, testosterone synthesized by Leydig cells is the primary endocrine and/or paracrine factor concerned in the regulation of testicular development, initiation of spermatogenesis and formation of secondary sexual characteristics. Although testosterone is recognized as the principal sex steroid in the male, estrogens are produced in the testis and levels within the male reproductive tract are generally higher than in the general circulation (reviewed by Hess 2000) . However, the role of estrogens in male reproduction is not fully understood and thus extensively studied (for review see Carreau et al. 2002) . Aromatase inhibitors reduce spermatid maturation in rat and monkey (Shetty et al. 1998 ). Moreover, male mice which lack a functional aromatase gene (ArKO) (Robertson et al. 1999) or -estrogen receptors (ER -KO) (Eddy et al. 1996) show alterations of spermatogenesis and become progressively infertile. The demonstration of the presence of estrogen receptor (ER ) in human (Enmark et al. 1997 , Saunders et al. 2001 , mouse (Rosenfeld et al. 1998) and rat (Saunders et al. 1998 , Van Pelt et al. 1999 germ cells is in favor of a local role for estrogens in spermatogenesis. The ability of the testis to transform androgens into estrogens is related to the presence of a microsomal enzymatic complex called aromatase. This enzyme is composed of a specific cytochrome P450 aromatase (P450 arom) and a ubiquitous NADPH-cytochrome P450 reductase (Simpson et al. 1994) . The aromatase complex is located in the endoplasmic reticulum of the cells and present in numerous tissues. The analysis of transcript and genomic sequences indicates that the tissue-specific expression of P450 arom is regulated in part by the use of an alternatively spliced untranslated first exon (Simpson et al. 1997 , Conley & Hinshelwood 2001 . The localization of aromatase within the testis has been a subject of considerable interest for a number of years (for review see Carreau et al. 1999) . In the rat there is an age-related change in the cellular localization of the aromatase which is first present in Sertoli cells of immature animals, then located in Leydig and germ cells (pachytene spermatocytes (PSs) and round spermatids (RSs)) in adults (Papadopoulos et al. 1986 , Levallet & Carreau 1997 , Levallet et al. 1998a . Nevertheless, there is little information concerning the regulation of the testicular P450 arom, especially in germ cells, which prompted us to study the control of Cyp19 gene expression in order to throw light on the regulation of the androgen/estrogen testicular balance. Therefore the aim of this work was to evaluate in vitro the putative role of steroid hormones (testosterone, 5 -dihydrotestosterone (DHT), estradiol) and steroid antagonists (nilutamide and ICI 182,780) in aromatase gene expression in purified PSs and RSs from adult male rat; in parallel the estradiol outputs have been measured. In this report we show that both androgen and estrogen direct specifically the aromatase gene expression in rat germ cells.
Materials and methods
Adult male Sprague-Dawley rats (95 10 days) were used for this study; they were housed under a controlled light cycle (12 h light:12 h darkness) and were given standard food and water freely according to the instructions of the University Animal Care Committee.
Germ cell purification
Testicular mixed germ cell preparation was obtained by the trypsin-DNase procedure with some modifications (Meistrich et al. 1981 , Levallet et al. 1998b . Briefly, after enzymatic digestion, the cell suspension was washed in PBS supplemented with 3·3 mM glucose and 6 mM pyruvate (Sigma). The resulting suspension was filtered first through fine nylon mesh to remove Sertoli cell aggregates, and then through glass wool to minimize spermatozoa content in the preparation. Further separation of testicular cell types was accomplished by unit gravity sedimentation through a BSA (Roche, Mannheim, Germany) gradient (0·2-2·75%) in a Sta-Put apparatus (Bellve et al. 1977) . PS-and RS-containing fractions were identified under a phase-contrast microscope, and the highest homogeneity fractions were pooled and washed at least three times with PBS. These germ cells had a purity greater than 95% as shown by the absence of somatic cell contamination when examined microscopically (morphological characterization) and assessed by other criteria, such as histochemical staining and RT-PCR. 3 -Hydroxysteroid dehydrogenase (3 -HSD) histochemical staining, a specific marker of Leydig cells, was used to analyze the purity of germ cell fractions. To estimate the Sertoli cell contamination of the germ cell preparations a histochemical staining with Oil Red O (Chapin et al. 1987) was performed. In addition, an RT-PCR technique was applied to amplify stem cell factor (or Steel Cell Factor, SCF), a known Sertoli cell marker (Rossi et al. 1993 ) and fibronectin (Fbr), a peritubular myoid cell product (Tung et al. 1984) . Purified germ cells were subsequently used for incubation and microsomal extraction. The viability of germ cells before and after incubation was evaluated using the trypan blue exclusion test (Sigma); the stained cells were considered to be dead.
Incubation procedure
The cells were incubated (2·5 10 6 PSs and 4·5 10 6 RSs) at 32 C under an humidified atmosphere of 5% CO 2 and 95% air in 1 ml Ham's F-12/DME medium (Seromed, Berlin, Germany) containing NaHCO 3 (1·2 g/l), Hepes (3·57 g/l) streptomycin (150 µg/ml), penicillin (30 µg/ml) and Fungizone (0·25 µg/ml) (Sigma) and supplemented with 10 mM pyruvate and 6 mM glucose. Germ cells were cultured in the presence or in the absence of increasing doses of testosterone as well as for various times of incubation (0-18 h). In order to verify the quality of germ cells after 18 h of treatment with or without 200 ng testosterone (7 10 7 M), a cytotoxicity test (MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay) was performed as described by Denizot & Lang (1986) . Germ cells were also cultured for 18 h with or without 5 -DHT (7 10 7 M), estradiol (1·8 10 9 M) (Sigma), anti-androgen (nilutamide; Hoechst Marion Roussel, Paris, France) and anti-estrogen (ICI 182,780; AstraZeneca, Cheshire, UK).
RT-PCR studies
The RNAgents total RNA isolation system (Promega, Charbonnieres, France) was used to extract RNAs from PSs and RSs. This reagent is an improvement of the single-step RNA isolation method developed by Chomczynski & Sacchi (1987) . The mRNA present in 500 ng total RNA was reverse transcribed into a cDNA as follows: 1 h at 37 C with 200 U Moloney murine leukemia virus (M-MLV) reverse transcriptase, 500 µM dNTPs, 0·2 µg oligo-dT (15-mer) and 24 U RNasin (Promega) in a final volume of 10 µl. The cDNAs obtained were further amplified by PCR using selected oligonucleotides. The primers were chosen to amplify a highly conserved sequence (289 bp length) including helical and aromatic regions of the P450 arom gene. PCR was performed during 35 cycles (30 s at 94 C, 30 s at 60 C, and 1 min at 72 C with 2 s delay at 72 C for each cycle) with 50 pmol primer (Table 1 ) and 1·5 U Taq polymerase (Promega) in a final volume of 50 µl. The amplified products were subjected to electrophoresis on 2% agarose gel stained with ethidium bromide. Sertoli or peritubular myoid cell contamination in germ cell preparations was assessed by co-amplifying SCF (a Sertoli cell marker) or Fbr (a myoid cell marker) transcripts with aromatase mRNA in the same aromatase PCR conditions.
The androgen receptor (AR) mRNA amplification was performed as described above with a set of primers (Table 1) targeted to the hormone-binding domain of the rat AR gene, which produced a 496 bp fragment. PCR was performed for 35 cycles (1 min at 94 C, 45 s at 60 C and 2 min at 72 C) with a final step of elongation at 72 C for 10 min.
Using a highly specific quantitative competitive RT-PCR method (Levallet et al. 1998a) , the amount of P450 arom mRNA present in the total RNA extracted from PSs and RSs was determined. The RNA standard was prepared by internal nucleotide deletion of 29 bp from 289 bp amplified product (Levallet et al. 1998a) . Thus for quantitative competitive RT-PCR measurements, increasing dilutions of RNA standard were added to a known amount of total RNA. After amplification with the appropriate set of primers (Table 1) in the same conditions as described above, the PCR products were run on a 4% agarose gel stained with ethidium bromide (Fig. 1) . The intensity and surface of each band were calculated and the sample/standard ratio was plotted against standard concentration, and then the quantity of P450 arom mRNA present in the total RNA was determined (Genissel et al. 2001) . Thompson & Siiteri (1974) 
Estradiol determinations
In germ cell culture media, 17-estradiol was measured by RIA according to previously reported method (Carreau et al. 1988) . Briefly, after incubation germ cells were pelleted and used for RNA extraction; steroids were then extracted from culture media by 10 volumes of diethyl ether. A highly specific estradiol antibody developed in rabbits was obtained from P.A.R.I.S (Compiègne, France) and labeled 17-estradiol from New England Nuclear. The average recoveries were between 88 and 98%, and the detection limit of the RIA was 6 pg/ml. The intra-assay coefficient of variation was 8%. An inter-assay coefficient of variation was not applicable since all the samples were run in a single assay. Cross-reactivities of the Figure 1 Quantitative competitive RT-PCR of total RNA from adult rat RSs. P450 arom mRNA was co-amplified with serial dilutions of RNA standard (lanes 1-7). Lane 8: RT-PCR performed using rat ovary mRNA as the positive control. Lane 9: an internal control (water instead of RNA). The amplified products were subjected to electrophoresis on 4% agarose gel; the gel was photographed and analyzed by densitometry. The P450 arom mRNA content was estimated by the determination of the equivalence point, according to the equation established by Menzo et al. (1992) .
antibody with other steroids, such as testosterone, progesterone and diethylstilbestrol were less than 0·05% as determined by the manufacturer.
Statistical analysis
All data are expressed as means S.E.M. of triplicate determinations performed at least three times with independent cell preparations. Statistical analysis was performed using ANOVA and means were compared using the Tukey-Kramer test; statistical significance was accepted at P,0·05.
Results
P450 arom mRNA level and aromatase activity in purified adult rat germ cells
As shown in Fig. 2A , after RT-PCR a single band was present in seminiferous tubules as well as in purified PSs and RSs and in rat ovary used as a positive control, whereas no signal was detected in adult Sertoli cells. The amplified cDNA fragment had the correct predicted size of 289 bp expected from the P450 arom-specific primers used. After Sta-Put, the purity of germ cell fractions was checked under a microscope and using various testicular somatic cell markers. Microscopic analysis based on morphological characterization revealed that our two germ cell fractions' purities were routinely higher than 95%. The major contaminants (2-5%) were other stages of spermatocytes and some RSs in the PS fraction, and some elongated spermatids in the RS fraction.
Germ cell preparations used in our study are devoid of Sertoli cell contamination, as shown by the specific Sertoli cell coloration (Oil Red O), which was negative, and RT-PCR, which failed to detect SCF, a putative Sertoli cell marker (Fig. 2B) . Likewise, Fbr, a peritubular myoid cell marker, was only detected in seminiferous tubules and myoid cells and not in germ cells preparations (Fig. 2C) . In both PS and RS preparations, no positive 3 -HSD cells were observed. Therefore these data unequivocally demonstrate the purity of the germ cell fractions used in the present work.
The aromatase activities were 89 21 and 158 10 fmol/mg protein/h respectively in PSs and RSs, which confirmed that the specific transcript for aromatase in germ cells was fully translated in a functional protein.
Effect of androgens on the amounts of aromatase transcripts and estradiol in germ cells
The treatment of purified germ cells with testosterone (10-200 ng/ml; 0·35-7 10 7 M) for 18 h resulted in a dose-related increase in P450 arom mRNA levels (Fig. 3) . In PSs the level of aromatase transcripts was enhanced 2-fold in the presence of 200 ng/ml testosterone when compared with untreated cells (Fig. 3A) . The amounts of P450 arom mRNA were not significantly different after 6 h of incubation, in either the absence or the presence of testosterone (200 ng/ ml), when compared with untreated cells (Fig. 3B) ; conversely after 18 h of incubation a 2-fold increase of P450 arom mRNA level was observed in the presence of testosterone when compared with untreated PSs for the same time (Fig. 3B) . In RSs, testosterone induced a strong up-regulation of aromatase mRNA levels; the maximum effect was obtained with 200 ng/ml testosterone (2·8-fold increase when compared with control cells, Fig.  3C ). Again the quantity of P450 arom mRNA was unaffected after 6 h of incubation in both the absence or the presence of testosterone vs initial time; thereafter a maximal increase (3-fold) was recorded after 18 h of treatment with testosterone when compared with untreated cells for the same time (Fig. 3D) . In the absence of treatment the level of transcripts increased according to time but remained 3-fold lower after 18 h of incubation when compared with testosterone-treated RS (Fig.  3D) . To demonstrate that testosterone was not cytotoxic for PSs and RSs, cell viability was assessed using the MTT assay, which is targeted to mitochondrial function. The results confirmed that testosterone (200 ng/ml) did not affect cell viability, as indicated by the equivalent mitochondrial activity in control and testosterone-treated germ cells (data not shown). In addition to the MTT test, the trypan blue exclusion assay did not show any significant difference in terms of cell viability (.98%) between untreated or testosterone-treated PSs or RSs. Therefore an 18 h incubation period was chosen for all further experiments.
In order to find out whether the increases of aromatase gene expression were or were not related to a true androgenic effect, we incubated PSs and RSs with 5 -DHT (a non-aromatizable androgen). 5 -DHT (200 ng/ml, 18 h) enhanced the aromatase mRNA levels in PSs (Fig. 4A ) and in RSs (Fig. 4B) with the same magnitude as with testosterone. Simultaneously the estradiol output followed the same pattern as for the gene expression and the increases were 42 and 62% (P,0·05) respectively when PSs and RSs were treated with testosterone. As expected 5 -DHT had no effect on the estradiol output ( Fig. 4C  and D) . 
Effect of estradiol and of an ER antagonist (ICI 182,780) on P450 arom mRNA levels in germ cells
Further, we wanted to verify if the stimulating effect of testosterone on germ cell aromatase mRNA expression was mediated by its conversion into estradiol, which in turn will act via the ER. In fact after 18 h of incubation with estradiol (0·5 ng/ml; 1·8 10 9 M) a significant decrease of Cyp19 gene expression was observed in PS and RS (respectively 28 and 46%, Fig. 5A and B) . That estradiol concentration was sufficient to cause a significant decrease of aromatase mRNA level in germ cells (a dose-related study with higher amounts of estradiol was performed and the results were similar; data not shown).
To provide evidence of a role for estrogen in the regulation of the aromatase gene expression we wanted to determine if ERs were involved, and for this we used the highly potent antagonist ICI 182,780. In addition, since testosterone was concerned also in Cyp19 gene expression either directly or via its transformation into estradiol, germ cells were treated with testosterone in either the absence or the presence of ICI 182,780 (10 7 M). The negative role exerted by estradiol on P450 arom mRNA expression in PSs and RSs was abolished in the presence of ICI 182,780 ( Fig.  5A and B) . Conversely ICI 182,780 did not affect either basal or testosterone-stimulated P450 arom mRNA levels. The trypan blue assay did not show any significant difference, in terms of cell viability (.98%), between untreated or ICI 182,780-treated PSs or RSs.
Effect of an AR antagonist (nilutamide) on the amounts of aromatase mRNA in purified germ cells
Nilutamide (10 6 -10 8 M) completely suppressed the stimulatory effect of testosterone on aromatase mRNA expression in germ cells; therefore this observation favored a testosterone effect via an AR ( Fig. 6A and B) . By itself nilutamide did not influence P450 arom expression. Our preliminary data obtained using the RT-PCR method and a specific set of primers targeted to amplify the hormone-binding domain of the rat AR gene showed a single band in purified PSs and RSs as well as in rat ovary and adult Sertoli cells used as positive controls. The amplified cDNA fragment had the correct predicted size of 496 bp (Fig. 6C ).
Discussion
Our results confirm that germ cells represent an additional source of estrogens in the male adult rat gonad (Nitta et al. 1993 , Janulis et al. 1998 , Levallet et al. 1998a , and in addition we demonstrate for the first time that steroids (testosterone and estradiol) direct Cyp19 gene expression in PSs and RSs. Indeed despite numerous reports focused on aromatase, especially in rodent testes, the regulation of aromatase gene expression has not been extensively studied in purified testicular cells, except in rat Sertoli cells (Levallet & Carreau 1997) and in mature rat Leydig cells (Genissel & Carreau 2001) . The regulation of the aromatase gene was studied using a quantitative competitive RT-PCR method developed in our laboratory (Genissel et al. 2001) . Because of the high sensitivity of that assay, the cellular fractions should be highly purified; therefore we have carefully analyzed the germ cell preparations using on the one hand specific Leydig cell and Sertoli cell markers (respectively 3-HSD activity, Oil Red O staining and the presence of SCF mRNA) and on the other hand using Fbr, a highly specific peritubular cell marker. Overall these observations show that the germ cell preparations were highly pure and only contaminated by other germ cells (less than 5%).
In both PSs and RSs we have observed that, in vitro, testosterone positively controls (in a time-and dose-related manner) aromatase gene expression with a simultaneous increase of estradiol output; furthermore, the same effect was obtained in terms of gene transcriptional activity with 5 -DHT (a testosterone metabolite resistant to aromatase activity) but these stimulatory effects were inhibited by nilutamide, a non-steroidal anti-androgen. Data have been reported showing a positive role for androgens in aromatase expression in rat testicular somatic cells; these studies were in the presence of a saturating amount of testosterone (200 ng/ml) (Levallet & Carreau 1997 , Genissel & Carreau 2001 . Moreover in the rat brain (Roselli & Resko 1984) as well as in the brain of male rhesus monkeys (Resko et al. 2000) androgens regulate aromatase at both the transcriptional level and the enzyme activity via the presence of ARs (Roselli et al. 2001) . In male gonad the localization of AR is a subject of controversy (for review see Eddy 2002); some reports have demonstrated the presence of immunoreactive AR in germ cells (Vornberger et al. 1994 , Zhou et al. 1996 and other studies have shown that only testicular somatic cells express AR (Suarez-Quian et al. 1999) . Using the RT-PCR technique we have revealed the presence of an AR mRNA in our two populations of highly purified germ cells. This 496 bp fragment contains the hormone-binding domain that confers the high specificity for these AR transcripts. The existence of a biologically active AR needs further work, even though the sequence of PCR products from our purified germ cells share more than 91% identity with the published AR sequence, at least for sequenced nucleotides which encompass the ligandbinding domain of the gene (Chang et al. 1998) . In that context, in man Wilson & McPhaul (1996) reported the presence of two AR isoforms, and in the eel Toshitaka et al. (1999) have cloned a novel AR subtype. In addition the existence of a rat testis-specific AR interacting protein (ARIP3) located in nuclei of Sertoli cells, spermatogonia and spermatocytes which recognizes the zinc finger domain of AR and modulates AR-dependent transcription has been reported (Moilanen et al. 1999) . In fact until now the mechanisms by which androgens regulate spermatogenesis in mammals have not been completely elucidated, since the site of androgen action remains unclear.
Conversely in the male genital tract the existence of ERs is well documented (Carreau et al. 2002 ; therefore we have compared the effect of testosterone on P450 arom mRNA expression with that of estradiol in order to clarify further the role of testosterone, which may be efficient via its conversion into estradiol. In germ cells our data show that testosterone induced a dose-dependent increase in the amounts of P450 arom mRNA, whereas estradiol provoked an opposite effect. Furthermore, the inhibitory effect of estradiol on aromatase gene expression was abolished in the presence of the ER antagonist ICI 182,780 and this ER antagonist did not affect either basal or testosterone-stimulated aromatase gene expression, suggesting that testosterone and estradiol use distinct signaling pathways to direct aromatase gene expression. We may also consider the putative role of androgen derivatives (5 -androstanediol and 5 -androstenediol) which may activate ER (Kuiper et al. 1997) , which is largely expressed in germ cells (Enmark et al. 1997) . Numerous studies in ERKO (Couse & Korach 1999) and ArKO mice (Robertson et al. 1999) are in favor of a positive role for estrogens in testicular functions (O'Donnell et al. 2001 , Carreau et al. 2002 . It has been shown that estrogens act as a germ cell survival factor (anti-apoptotic role) in the human testis (Pentikaïnen et al. 2000) . In addition our observations in the bank vole testis showing a positive correlation between the expression of P450 arom, ER and ER in germ cells together with a recrudescence of spermatogenesis (Bilinska et al. 2001 ) and the positive effect of estradiol after in vivo treatment on the development of spermatogenesis in the hamster (Pak et al. 2002) clearly favored the above hypothesis related to the importance of estrogens in testicular functions. Concerning the regulation of the aromatase gene in adult rat Leydig cells, Genissel et al. (2001) demonstrated a positive effect of estradiol on P450 arom mRNA expression, whereas we show that estradiol at the same dose down-regulates aromatase gene expression in PSs and RSs, suggesting the presence of estrogen responsive elements on the rat aromatase promoter as described in the rabbit, in which three estrogen responsive elements are found in the 5 flanking region of the aromatase gene (Bouraïma et al. 2001) . These estrogen effects are obviously related to the existence of ERs, which are strongly expressed not only by the somatic cells but also by the differentiating and proliferating germ cells of mammalian testes. It should be added that not only conventional ER and ER exist in testicular cells but also biologically active isoforms have been described recently for both ER (Brand et al. 2002) and ER , which obviously opens new considerations about the physiological potencies of estrogens in the spermatogenetic processes.
In summary, these steroid hormones should be added to the other regulatory controls involving especially cytokines (Bourguiba et al. 2003) which direct the expression of the Cyp19 gene in rat germ cells. Using an in vitro model of mature rat PSs and RSs, we have shown that androgens stimulate the expression of the aromatase gene in these cells, whereas estrogens down-regulate this expression. Therefore rat testicular aromatase is controlled at least at the transcriptional level by locally produced modulators and among them steroid hormones, suggesting that the rat aromatase promoter(s) contains androgen and estrogen responsive elements whose localization is not yet known but which is under investigation using 5 RACE experiments.
